Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bernstein Upgrades Eni to Outperform

Bernstein Upgrades Eni to Outperform

Bernstein analyst Oswald Clint upgrades Eni (NYSE:E) from Market Perform to Outperform.

byBenzinga Newsdesk

January 3, 2023

1 minute read

Bernstein analyst Oswald Clint upgrades Eni (NYSE:E) from Market Perform to Outperform.

SVB Leerink Maintains Outperform on Repligen, Raises Price Target to $250

By Benzinga Newsdesk

August 3, 5:02 AM

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $220 to $250.

RGEN

Strategic Organizing Center Releases Investor Presentation Highlighting On Why Board Change Is Needed Now In Order To “Brew A Better Starbucks”

By Benzinga Newsdesk

February 20, 10:24 AM

Details why Starbucks' flawed human capital management strategy is the most critical issue facing the Company today and how the Board's failed oversight has cost shareholders, employees and customersBelieves that the

SBUX

Analyst Ratings

Where Reviva Pharmaceuticals Stands With Analysts

By Benzinga Insights

June 8, 9:02 AM

Reviva Pharmaceuticals (NASDAQ:RVPH) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

RVPH